NICE quality standards are a concise set of prioritised statements designed to drive measurable quality improvements within a particular area of health or care.

NICE quality standards are derived from high quality guidance such as that from NICE or other sources accredited by NICE.

This quality standard covers the identification and management of heterozygous familial hypercholesterolaemia (FH) in adults, young people and children. Homozygous FH has been excluded from this quality standard because it has a low incidence and people with homozygous FH need specialist care.